Universal reference book for medicines
Product name: BELODERM ® (BELODERM ® )

Active substance: betamethasone

Type: GCS for external use

Manufacturer: BELUPO, Pharmaceuticals & Cosmetics (Croatia)
Composition, form of production and packaging
?
Cream for external use 0.05% white, homogeneous, without mechanical inclusions.
1 g

betamethasone dipropionate 640 μg,

which corresponds to the content of betamethasone 500 μg

Auxiliary substances: chlorocresol, sodium dihydrogen phosphate monohydrate, phosphoric acid, petroleum jelly, mineral oil, macrogol cetostearate, cetostearyl alcohol (cetyl alcohol 60%, stearyl alcohol 40%), sodium hydroxide, water.

15 g - aluminum tubes (1) - cardboard packs.

20 g - aluminum tubes (1) - packs of cardboard.

30 g - aluminum tubes (1) - cardboard packs.

40 g - aluminum tubes (1) - packs of cardboard.

?
Ointment for external use 0.05% white, translucent, homogeneous.
1 g

betamethasone dipropionate 640 μg,

which corresponds to the content of betamethasone 500 μg

Excipients: mineral oil, petroleum jelly.

15 g - aluminum tubes (1) - cardboard packs.

20 g - aluminum tubes (1) - packs of cardboard.

30 g - aluminum tubes (1) - cardboard packs.

40 g - aluminum tubes (1) - packs of cardboard.

INSTRUCTION FOR THE SPECIALIST.

The product description was approved by the manufacturer for the 2009 print edition.

PHARMACHOLOGIC EFFECT

GCS for external use.
Has anti-inflammatory, antipruritic, anti-allergic, vasoconstrictive, antiexudative and antiproliferative action.
When applied to the skin surface, the drug has a quick and powerful effect in the inflammation focus, reducing the severity of objective symptoms (erythema, edema, lichenification) and subjective sensations (itching, irritation, pain).

PHARMACOKINETICS

Data on the pharmacokinetics of the drug Beloderm are not provided.

INDICATIONS

The conditions under which effective therapy with topical GCS, including:

- atopic dermatitis;

- Neurodermatitis;

allergic contact dermatitis;

- Eczema (various forms);

contact dermatitis (including professional dermatitis);

- non-allergic dermatitis (including sun and radiation dermatitis);

- reactions to insect bites;

- psoriasis;

- bullous dermatoses;

- discoid lupus erythematosus;

- Red flat lichen;

- exudative erythema multiforme;

- itchy skin of different etiology.

DOSING MODE

The drug is intended for external use only.

Cream or ointment for external use applied to the affected area of ​​the skin with a thin layer 2 times / day, lightly rubbing.
On sites with denser skin (for example, elbows, palms and feet), as well as places from which the drug is easily erased, the drug can be applied more often. The duration of continuous treatment is usually not more than 4 weeks.
For the prevention of relapse in the treatment of chronic diseases, therapy should continue for some time after the disappearance of all symptoms.

During the year, repeated courses of therapy are possible.

The cream for external use is used for acute therapy, including.
wetting skin lesions.
Ointment for external use is intended for the therapy of subacute and chronic dermatoses, incl.
dry, lichenic and flaky lesions, or in cases where the occlusive effect of the ointment is necessary.
SIDE EFFECT

Side effects, as a rule, are slightly expressed.

Dermatological reactions: rarely - hypersensitivity reactions (itching, burning, hyperemia), acne-like changes, hypopigmentation, striae, skin atrophy, hypertrichosis, telangiectasia, secondary skin infections.

When developing a hypersensitivity reaction or adverse reactions, the drug should be discarded.

CONTRAINDICATIONS

- Tuberculosis of the skin;

- cutaneous manifestations of syphilis;

- chickenpox;

- viral, bacterial and fungal skin infections;

- skin postvaccinal reactions;

- open wounds;

- trophic ulcers;

- rosacea;

- Acne vulgaris;

- tumors of the skin and subcutaneous structures;

- Children's age up to 6 months;

- Hypersensitivity to betamethasone or to any of the auxiliary components of the drug.

PREGNANCY AND LACTATION

The use of Beloderm in pregnant women is allowed in cases where the intended use for the mother exceeds the risk to the fetus.
In such cases, the use of the drug should be short and limited to small areas of skin.
During breastfeeding, the drug can be used according to strict indications, but the drug should not be applied to the skin of the breast before feeding.

APPLICATION FOR CHILDREN

The drug can be administered to children from 6 months with caution and for as short a time as possible.
Do not apply the drug under the bandages and, especially under plasticized diapers, because this increases the absorption of the drug and increases the risk of side effects.
SPECIAL INSTRUCTIONS

It is not recommended to use the product on the face for a long time, since
possible the development of rosacea, perioral dermatitis and acne.
The drug should not be used in the eye area, due to the likelihood of the drug getting on the mucous membrane, which can contribute to the development of cataracts, glaucoma, fungal infections of the eye and exacerbation of herpetic infection.

Some areas of the body, such as axillary cavities, inguinal folds where there is natural occlusion, are more susceptible to the risk of streaking, so the use of the drug in these areas of the skin should be short-lived.

With the development of fungal or bacterial infection on the skin, it is necessary to use an additional antibacterial or antifungal agent.

Use in Pediatrics

The drug can be administered to children from 6 months with caution and for as short a time as possible.
Do not apply the drug under the bandages and, especially under plasticized diapers, because this increases the absorption of the drug and increases the risk of side effects.
Impact on the ability to drive vehicles and manage mechanisms

Data on the adverse effect of the drug Beloderm on the ability to drive vehicles and mechanisms is not available.

OVERDOSE

With prolonged continuous use of the drug, especially in children, on extensive skin surfaces, when applied to the skin with impaired integrity or when used under an occlusive dressing, it is possible to develop side effects associated with suppression and insufficiency of adrenal cortex function.

Treatment: it is recommended to cancel the drug and, if necessary, to prescribe symptomatic therapy.

DRUG INTERACTION

The interaction of the drug Beloderm with other drugs is unknown.

TERMS OF RELEASE FROM PHARMACY

The drug is approved for use as a means of OTC.

TERMS AND CONDITIONS OF STORAGE

The drug should be stored out of reach of children at a temperature of no higher than 25 ° C.
Shelf life - 4 years.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y
Rambler's Top100
Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!